Dubai: Multinational food giant announces new production unit.(NESTL&Eacute)

Middle East | February 11, 2007 | Copyright

In a milestone development NESTLÉ Middle East yesterday announced an investment of over US$50 million in a state-of-the-art production facility in Techno Park, a fully owned subsidiary of Economic Zones World. The move is a major step forward in strengthening company's leadership across the Middle East.

The groundbreaking ceremony for the new production unit was jointly headed yesterday by Jamal Majid Bin Thaniah, Vice Chairman, Board of Ports and Free Zones, Ms. Salma Hareb, CEO of Jafza & Economic Zones World and Mr. Frits Van Dijk, Executive Vice President ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Gliatech Receives Allowance of U.S. Patent Claims for Anti-Properdin Technology.
PR Newswire ; ...patent claims covering the use of anti-properdin agents as treatments to inhibit harmful...developing therapeutic antibodies to properdin as potential treatments for acute inflammatory...our intellectual property around anti-properdin agents and their promising utility as...
Gliatech receives allowance of United States patent claiming therapeutic antibodies to properdin.(Brief Article)
Newspaper article from: BIOTECH Patent News ; ...patent claims covering the use of anti-properdin agents as treatments to inhibit harmful...developing therapeutic antibodies to properdin as potential treatments for acute inflammatory...our intellectual property around anti-properdin agents and their promising utility as...
GLIATECH, ABGENIX IN PROPERDIN ANTIBODY DEAL FOR UP TO $40M.(Brief Article)
Magazine article from: BIOWORLD Today ; ...license to develop and commercialize anti-properdin antibody therapies for all indications...monoclonal antibody therapies against properdin, a complement protein. Gliatech gets...technology to make antibodies targeted at the properdin antigen. Gliatech had been working in...
California Inventors Develop Anti-Properdin Antibodies
News Wire article from: US Fed News Service, Including US State News ; ...Calif., and Gerardo Zapata of San Mateo, Calif., have developed antibodies, and in particular, antibodies specific for properdin, the U.S. Patent & Trademark Office announced. The inventors were issued U.S. Patent No. 7,423,128 on Sept...
Research from Leiden University, Department of Nephrology provides new data on kidneys.
Newspaper article from: Biotech Week ; ...activation by tubular cells is mediated by properdin binding,' is now available. "Activation...activation indicate a key role for properdin in the initiation of an alternative pathway. We hypothesized that properdin serves as a focal point for complement...
New discovery on role of vital protein that fights meningitis.
Newspaper article from: Health & Medicine Week ; ...The study also reveals that the same protein, Properdin udiscovered only half a century ago- can also harm...the first line immune defence, a protein called Properdin. "Properdin deficiency in families, though rare, predisposes...
Abgenix Licenses From Gliatech Antibody Product Candidates for Cardiovascular and Inflammatory Diseases; IND Planned for 2002.
Business Wire ; ...therapies against the complement protein properdin as potential treatments for cardiovascular...application to the FDA for an anti-properdin antibody product candidate next year...license to develop and commercialize anti-properdin antibody therapies for all indications...
Love, honor, draw blood ; At this wedding, the newlyweds and their guests all rolled up their sleeves to help find a genetic killer.
Newspaper article from: Sunday News Lancaster, PA ; ...their mother, said Morton, and that is properdin deficiency. The clinic sent the blood of the surviving cousin to be tested for properdin and found that it was missing. Once the clinic knew that properdin deficiency was the risk factor, said...
Monoclonal Antibody Has Potential in Reducing Heart Attack Damage.
Newspaper article from: Immunotherapy Weekly ; ...has previously shown that its anti-properdin MAbs effectively block complement activation...In the most recent study, an anti-properdin MAb was shown to significantly reduce...These data further suggest that an anti-properdin MAb may also have clinical utility in...
Gliatech's Monoclonal Antibody Indicates Potential in Myocardial Ischemia.
PR Newswire ; ...has previously shown that its anti-properdin MoAbs effectively block complement activation...In the most recent study, an anti- properdin MoAb was shown to significantly reduce...data further suggests that an anti-properdin MoAb may also have clinical utility in...

Find more facts and information related to the article "Dubai: Multinational food giant announces new ..."